Specifically, APRIL preferably binds to BCMA with much higher affinity than BAFF [83,99] and is predominantly produced by myeloid cells, macrophages, OC precursor cells, and OCs which play central pathophysiological roles in MM-induced bone lesions. This evidence concerns the gene TNFSF13 and Miyoshi myopathy.